ICAM1 and dry eye syndrome: In an in vitro model of AD-like symptoms (TNF-α and IFN-γ stimulated KCs), 310-nm and 340-nm ultraviolet light-emitting diodes (UV-LEDs) effectively inhibited STAT1 signaling and suppressed inflammation by downregulating ICAM-1.